Cargando…

Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia

Pediatric acute myeloid leukemia (AML) represents 20% of total childhood leukemia diagnoses and is characterized by poor prognosis with a long-term survival rate around the 50%, when patients are properly treated. The standard treatment for pediatric AML currently consists in a combination of cytara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Argenziano, Maura, Tortora, Chiara, Paola, Alessandra Di, Pota, Elvira, Martino, Martina Di, Pinto, Daniela Di, Leva, Caterina Di, Rossi, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274721/ https://www.ncbi.nlm.nih.gov/pubmed/34262648 http://dx.doi.org/10.18632/oncotarget.28000

Ejemplares similares

Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells
por: Di Paola, Alessandra, et al.
Publicado: (2021)

Osteosarcoma in Children: Not Only Chemotherapy
por: Argenziano, Maura, et al.
Publicado: (2021)

Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis
por: Punzo, Francesca, et al.
Publicado: (2018)

Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors
por: Rossi, Francesca, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors
por: Rossi, Francesca, et al.
Publicado: (2022)

Can Denosumab be used in combination with Doxorubicin in Osteosarcoma?
por: Punzo, Francesca, et al.
Publicado: (2020)

Effect of CB2 Stimulation on Gene Expression in Pediatric B-Acute Lymphoblastic Leukemia: New Possible Targets
por: Punzo, Francesca, et al.
Publicado: (2022)

Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells
por: Punzo, Francesca, et al.
Publicado: (2020)

Osteoporosis in Childhood Cancer Survivors: Physiopathology, Prevention, Therapy and Future Perspectives
por: Rossi, Francesca, et al.
Publicado: (2022)

Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia
por: Di Paola, Alessandra, et al.
Publicado: (2020)

Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease
por: Tortora, Chiara, et al.
Publicado: (2022)

CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy
por: Argenziano, Maura, et al.
Publicado: (2023)

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
por: Rossi, Francesca, et al.
Publicado: (2020)

Correction: Argenziano, M., et al. The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases. Int. J. Mol. Sci. 2019, 20, 5875
por: Argenziano, Maura, et al.
Publicado: (2020)

The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases
por: Argenziano, Maura, et al.
Publicado: (2019)

Effects of CB2 and TRPV1 receptors’ stimulation in pediatric acute T-lymphoblastic leukemia
por: Punzo, Francesca, et al.
Publicado: (2018)

The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
por: Vogel, Jens-Uwe, et al.
Publicado: (2019)

Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Celiac Disease
por: Tortora, Chiara, et al.
Publicado: (2022)

Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication
por: Waters, Torin, et al.
Publicado: (2020)

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
por: Shi, Mingyue, et al.
Publicado: (2019)

The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
por: Rossi, Francesca, et al.
Publicado: (2019)

Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget’s Disease of Bone
por: Paoletta, Marco, et al.
Publicado: (2021)

Childhood Cancer Survivors: An Overview of the Management of Late Effects
por: Argenziano, Maura, et al.
Publicado: (2023)

Poikiloderma With Neutropenia and Mastocytosis: A Case Report and a Review of Dermatological Signs
por: Piccolo, Vincenzo, et al.
Publicado: (2021)

The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2023)

CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune Thrombocytopenia
por: Rossi, Francesca, et al.
Publicado: (2019)

Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
por: Kim, Dae Sik, et al.
Publicado: (2016)

Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
por: Mascolo, Annamaria, et al.
Publicado: (2020)

The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
por: Chan, Lap Shu Alan, et al.
Publicado: (2021)

Eltrombopag Modulates Reactive Oxygen Species and Decreases Acute Myeloid Leukemia Cell Survival
por: Kalota, Anna, et al.
Publicado: (2015)

Chronic Myeloid Leukemia in a Patient with Previous Idiopathic Thrombocytopenic Purpura: How to Manage Imatinib Together with Eltrombopag
por: Autore, Francesco, et al.
Publicado: (2021)

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
por: di Martino, Orsola, et al.
Publicado: (2019)

The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2022)

The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis
por: Shoukier, Mahran, et al.
Publicado: (2020)

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox
por: Palumbo, Giuseppe A., et al.
Publicado: (2021)

Time trends of cancer incidence in childhood in Campania region: 25 years of observation
por: Indolfi, Paolo, et al.
Publicado: (2016)

Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
por: Santoro, Cristina, et al.
Publicado: (2017)

Efficacy of Supplementation with Iron Sulfate Compared to Iron  Bisglycinate Chelate in Preterm Infants
por: Bagna, Rossana, et al.
Publicado: (2018)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8g5n5n0u6sv7vu425m53apr6k